The prevalence of attention-deficit/hyperactivity disorder (ADHD) diagnoses in the United States increased significantly from 1997 to 2016, reports a new study.
Using acetaminophen during just one trimester was associated with 7% higher odds of having a child with ADHD, while the increased risk was 22% for women who used the drug in two trimesters and 27% with use in all three trimesters, the study found.
An evening-dosed, delayed-release, long-acting formulation of methylphenidate led to significant improvements in children with ADHD, compared with placebo, in a phase 3 published study.
NEW ORLEANS—Fewer than 40% of health care providers who treat children and adults who have attention-deficit/hyperactivity disorder (ADHD) are satisfied with the treatment options available to them, researchers reported in a poster abstract presented at Psych Congress 2017.
Using medication for attention-deficit/hyperactivity disorder in adolescents and adults lowers their risk of substance abuse problems in the present and, at least for men, in the future, too, according to a newly published study.
The approval is based on results from 16 studies involving more than 1600 participants.